These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 12465085

  • 21. [Clozapine withdrawal. A review].
    Szafrański T, Gmurkowski K.
    Psychiatr Pol; 1999; 33(1):51-67. PubMed ID: 10786215
    [Abstract] [Full Text] [Related]

  • 22. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J, Urban A, Valis M, Malý R, Tůma I, Hosák L.
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
    Shoulson I.
    Adv Neurol; 1983 Mar; 37():259-66. PubMed ID: 6134445
    [No Abstract] [Full Text] [Related]

  • 31. Withdrawal from clozapine: the "rebound phenomenon".
    Durst R, Teitelbaum A, Katz G, Knobler HY.
    Isr J Psychiatry Relat Sci; 1999 Mar; 36(2):122-8. PubMed ID: 10472746
    [Abstract] [Full Text] [Related]

  • 32. Low dose perphenazine and levodopa/carbidopa therapy in a patient with Parkinsonism and a psychotic illness.
    Hale MS, Bellizzi J.
    J Nerv Ment Dis; 1980 May; 168(5):312-4. PubMed ID: 7365497
    [Abstract] [Full Text] [Related]

  • 33. Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.
    van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A.
    Eur J Clin Pharmacol; 2002 May; 58(2):157-61. PubMed ID: 12012150
    [Abstract] [Full Text] [Related]

  • 34. Milacemide therapy for Parkinson's disease.
    Giuffra ME, Sethy VH, Davis TL, Mouradian MM, Chase TN.
    Mov Disord; 1993 May; 8(1):47-50. PubMed ID: 8380487
    [Abstract] [Full Text] [Related]

  • 35. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.